(3-(Cyclopentyloxy)-4-methoxyphenyl)boronic acid, 95.0%, 1g

4-Amino-3,5-dichloro-2,6-difluoropyridine, 95.0%, 100g

5-Bromo-6-methylisoquinolin-1-amine, 98%, 250mg

1,3-Bis(3,3,3-trifluoropropyl)-1,1,3,3-tetramethyldisilazane>94.0%(GC)5g

5-(4-(Di-p-tolylamino)phenyl)thiophene-2-carbaldehyde, 98%, 5g

2-([1,1'-Biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine>98.0%(HPLC)(N)5g

Polyvinylpyrrolidone K 25, 5 kg

2-Amino-4-methylpentanamide, 95%, 5g

[S(R)]-N-[(1S)-1-[2-((tert-Butyldiphenylsilyl)oxy)phenyl)]-2-yl-2-(diphenylphosphino)ethyl]-2-methyl-2-propanesulfinamide, 95%, 50mg

6-(4-bromo-2-methylphenyl)-6-oxohexanoic acid, 97.0%, 2g

Trial kit Spectra/Por® 1-3 Spectra/Por® 3 - MWCO 3500, 54 mm, 1 Piece(s)

3-((3S,4S)-4-METHYL-3-(METHYL(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)AMINO)PIPERIDIN-1-YL)-3-OXOPROPANENITRILE, 95%, 50mg

6-Bromo-3-fluoro-2-methyl-pyridine, 98.0%, 10g